Pentoxifylline response in alloxan-induced diabetic rats

References

• Cullen JR, Cinnamond MJ. Hearing loss in diabetics. J Laryngol Otol 1993; 107: 179–82
   PubMed Web of Science ®Google Scholar
• Virtaniemi J, Laakso M, Nuutinen J, Karjalainen S, Vartiainen E. Hearing thresholds in insulin-dependent diabetic patients. J Laryngol Otol 1994; 108: 837–41
   PubMed Web of Science ®Google Scholar
• Lisowska G, Namyslowski G, Morawski K, Strojek K. Early identification of hearing impairment in patients with type 1 diabetes mellitus. Otol Neurotol 2001; 22: 316–20
   PubMed Web of Science ®Google Scholar
• Kakarlapudi V, Sawyer R, Staecker H. The effect of diabetes on sensorineural hearing loss. Otol Neurotol 2003; 24: 382–6
   PubMed Web of Science ®Google Scholar
• Buller N, Laurian N, Shvili I, Laurian L. Delayed brainstem auditory evoked responses in experimental diabetes mellitus. J Laryngol Otol 1986; 100: 883–91
   PubMed Web of Science ®Google Scholar
• Parving A, Elberling C, Balle V, Parbo J, Dejgaard A, Parving HH. Hearing disorders in patients with insulin-dependent diabetes mellitus. Audiology 1990; 29: 113–21
   PubMedGoogle Scholar
• Akinci A, Deda G, Karagol U, Tezic T. Brainstem auditory evoked potential, visual evoked potential and nerve conduction velocity and their relation with HbA1c and beta 2 microglobulin in children with insulin dependent diabetes mellitus. Turk J Pediatr 1994; 36: 279–87
   PubMedGoogle Scholar
• Seidl R, Birnbacher R, Hauser E, Bernert G, Freilinger M, Schober E. Brainstem auditory evoked potentials and visually evoked potentials in young patients with IDDM. Diabetes Care 1996; 19: 1220–4
   PubMed Web of Science ®Google Scholar
• Di Leo MA, Di Nardo W, Cercone S, Ciervo A, Lo Monaco M, Greco AV, et al. Cochlear dysfunction in IDDM patients with subclinical peripheral neuropathy. Diabetes Care 1997; 20: 824–8
   PubMed Web of Science ®Google Scholar
• Bayazit Y, Yilmaz M, Kepekci Y, Mumbuc S, Kanlikama M. Use of auditory brainstem response testing in the clinical evaluation of the patients with diabetes mellitus. J Neurol Sci 2000; 181: 29–32
   PubMedGoogle Scholar
• Erdem T, Ozturan O, Miman MC, Ozturk C, Karatas E. Exploration of the early auditory effects of hyperlipoproteinemia and diabetes mellitus using otoacoustic emissions. Eur Arch Otorhinolaryngol 2003; 260: 62–6
   PubMed Web of Science ®Google Scholar
• Makishima K, Tanaka K. Pathological changes of the inner ear and central auditory pathway in diabetics. Ann Otol Rhinol Laryngol 1971; 80: 218–28
   PubMed Web of Science ®Google Scholar
• Ishikawa T, Naito Y, Taniguchi K. Changes in the immunoreactivity of protein gene product (PGP) 9.5 in the cochlea of spontaneously diabetic WBN/Kob rats. Diabetologica 1997; 40: 173–8
   PubMedGoogle Scholar
• Lee Y, Robinson M, Wong N, Chan E, Charles MA. The effect of pentoxifylline on current perception thresholds in patients with diabetic sensory neuropathy. J Diabetes Complications 1997; 11: 274–8
   PubMedGoogle Scholar
• Gries A, Herr A, Kirsch S, Gunther C, Weber S, Szabo G, et al. Inhaled nitrous oxide inhibits platelet-leukocyte interactions in patients with acute respiratory distress syndrome. Crit Care Med 2003; 31: 1697–704
   PubMedGoogle Scholar
• Bucala R, Makita Z, Koschinsky T, Cerami A, Vlassara H. Lipid advanced glycosylation: pathway for oxidation in vivo. Proc Natl Acad Sci U S A 1993; 90: 6434–8
   PubMed Web of Science ®Google Scholar
• Wayz DK, Sheetz MJ. The role of protein kinase C in the development of the complications of diabetes. Vitam Horm 2000; 60: 149–93
   PubMedGoogle Scholar
• Kuboki K, Jiang ZY, Takahara N, Ha SW, Igarashi M, Yamauchi T, et al. Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulin. Circulation 2000; 101: 676–81
   PubMed Web of Science ®Google Scholar
• Duck SW, Prazma J, Bennett PS, Pillsbury HC. Interaction between hypertension and diabetes mellitus in the pathogenesis of sensorineural hearing loss. Laryngoscope 1997; 107: 1596–604
   PubMed Web of Science ®Google Scholar
• Ward A, Clissold SP. Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs 1987; 34: 50–97
   PubMed Web of Science ®Google Scholar
• Ernst E. Pentoxifylline for intermittent claudication. A critical review. Angiology 1994; 45: 339–45
   PubMed Web of Science ®Google Scholar
• Cesarone MR, Incandela L, Belcaro G, De Sanctis MT, Nicolaides AN, Griffin M, et al. Treatment of vascular inner ear disease in vascular patients with pentoxifylline: a controlled, randomized trial. Angiology 2002; 53(Suppl 1)S23–S26
   Google Scholar
• Flint H, Cotter MA, Cameron NE. Pentoxifylline effects on nerve conduction velocity and blood flow in diabetic rats. Int J Exp Diabetes Res 2000; 1: 49–58
   PubMedGoogle Scholar
• Sebag J, Tang M, Brown S, Sadun AA, Charles MA. Effects of pentoxifylline on choroidal blood flow in nonproliferative diabetic retinopathy. Angiology 1994; 45: 429–33
   PubMedGoogle Scholar
• LaRouere MJ, Sillman JS, Tsai MT, Nuttal AL. The effect of pentoxifylline on cochlear blood flow. Otolaryngol Head Neck Surg 1992; 106: 87–91
   PubMedGoogle Scholar
• Quirk WS, Dengerink HA, Bademian MJ, Hall KW, Wright JW. The effects of pentoxifylline on cochlear blood flow in normotensive and spontaneously hypertensive rats. Hear Res 1988; 36: 175–80
   PubMed Web of Science ®Google Scholar
• Lamm K, Arnold W. The effect of blood flow promoting drugs on cochlear blood flow, perilymphatic pO2 and auditory function in the normal and noise-damaged hypoxic and ischemic guinea pig inner ear. Hear Res 2000; 141: 199–219
   PubMed Web of Science ®Google Scholar
• Kellerhals B. Perilymph production and cochlear blood flow. Acta Otolaryngol 1979; 87: 370–4
   PubMed Web of Science ®Google Scholar
• Latoni J, Shivapuja B, Seidman MD, Quirk WS. Pentoxifylline maintains cochlear microcirculation and attenuates temporary threshold shifts following acoustic overstimulation. Acta Otolaryngol 1996; 116: 388–94
   PubMed Web of Science ®Google Scholar
• Franzini E, Sellak H, Hakim J, Pasquier C. Oxidative damage to lysozyme by the hydroxyl radical: comparative effects of scavengers. Biochim Biphys Acta 1993; 1203: 11–17
   PubMed Web of Science ®Google Scholar
• Federiuk IF, Casey HM, Quinn MJ, Wood MD, Ward WK. Induction of type-1 diabetes mellitus in laboratory rats by use of alloxan: route of administration, pitfalls, and insulin treatment. Comp Med 2004; 54: 252–7
   PubMed Web of Science ®Google Scholar